Serum cytokine change profile associated with hbsag loss during combination therapy with peg-ifn-α in nas-suppressed chronic hepatitis b patients

HIGHLIGHTS

  • who: Wen-Xin Wang and collaborators from the University, China have published the article: Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-u03b1 in NAs-suppressed chronic hepatitis B patients, in the Journal: (JOURNAL)
  • what: The authors investigated the dynamic changes of serum cytokines levels during PEG-IFN-a add-on therapy in NAssuppressed CHB patients with HBsAg levels and amp;lt; 1,500 IU/ml, and Existing databases and text mining showed that most of the cytokines involved in this study had co-expression relationships.

SUMMARY . . .

 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?